Schneider Eugene
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Schneider Eugene. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| IONS | EVP, Chf Clinical Develop Ofcr | Option Exercise | 19,658 | $53.77 | $1,057,011 | Sep 3, 2025 |
| IONS | EVP, Chf Clinical Develop Ofcr | Sale | 9,549 | $42.80 | $408,697 | Aug 4, 2025 |
| IONS | EVP, Chf Clinical Develop Ofcr | Award / Grant | 4,032 | — | — | Jan 31, 2025 |
| IONS | EVP, Chf Clinical Develop Ofcr | Sale | 6,523 | $32.79 | $213,889 | Jan 15, 2025 |
| IONS | EVP, Chf Clinical Develop Ofcr | Sale | 2,106 | $49.59 | $104,437 | Feb 2, 2024 |
| IONS | EVP, Chf Clinical Develop Ofcr | Sale | 2,071 | $49.59 | $102,701 | Feb 1, 2024 |
| IONS | EVP, Chf Clinical Develop Ofcr | Option Exercise | 15,162 | — | — | Jan 17, 2024 |
| IONS | EVP, Chf Clinical Develop Ofcr | Sale | 8,000 | $53.50 | $428,000 | Jan 12, 2024 |
| IONS | EVP, Chf Clinical Develop Ofcr | Sale | 25,000 | $51.46 | $1,286,500 | Dec 26, 2023 |
| IONS | EVP, Chf Clinical Develop Ofcr | Award / Grant | 4,033 | — | — | Feb 6, 2023 |
| IONS | EVP, Chf Clinical Develop Ofcr | Sale | 4,752 | $39.57 | $188,037 | Jan 17, 2023 |
| IONS | EVP, Chf Clinical Develop Ofcr | Tax Withholding | 144 | $46.52 | $6,699 | Oct 17, 2022 |
| IONS | EVP, Chf Clinical Develop Offc | Tax Withholding | 3,815 | $30.12 | $114,908 | Jan 18, 2022 |
| IONS | EVP, Chf Clinical Develop Offc | Option Exercise | 417 | — | — | Oct 15, 2021 |
| IONS | EVP, Chf Clinical Develop Offc | Option Exercise | 7,503 | — | — | Jan 15, 2021 |